BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27938993)

  • 21. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multimodality approach to sinonasal undifferentiated carcinoma: a single institute experience.
    Bhasker S; Mallick S; Benson R; Bhanuprasad V; Sharma A; Thakar A
    J Laryngol Otol; 2017 Jan; 131(1):19-25. PubMed ID: 27938440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database.
    Khan MN; Konuthula N; Parasher A; Genden EM; Miles BA; Govindaraj S; Iloreta AM
    Int Forum Allergy Rhinol; 2017 Feb; 7(2):205-210. PubMed ID: 27717204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
    Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
    Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma.
    Nakamura Y; Suzuki M; Ozaki S; Yokota M; Nakayama M; Hattori H; Inagaki H; Murakami S
    Auris Nasus Larynx; 2019 Aug; 46(4):641-650. PubMed ID: 30545727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings of the 2023 North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Navigating New Developments in High Grade Sinonasal Neuroendocrine and Neuroectodermal Neoplasms.
    Rooper LM
    Head Neck Pathol; 2023 Jun; 17(2):299-312. PubMed ID: 37184733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
    Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
    J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy.
    Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE
    Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sinonasal undifferentiated carcinoma metastatic to the skin.
    Sohsman M; Yang HM; Cassarino DS
    J Cutan Pathol; 2010 Dec; 37(12):1241-4. PubMed ID: 19682175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival of a patient with primary small cell neuroendocrine carcinoma of the maxillary sinus: a case report.
    Hosokawa S; Okamura J; Takizawa Y; Mineta H
    J Oral Maxillofac Surg; 2013 Aug; 71(8):e248-52. PubMed ID: 23866955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sinonasal Undifferentiated Carcinoma.
    Abdelmeguid AS; Bell D; Hanna EY
    Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes.
    De Cecco L; Serafini MS; Facco C; Granata R; Orlandi E; Fallai C; Licitra L; Marchesi E; Perrone F; Pilotti S; Quattrone P; Piazza C; Sessa F; Turri-Zanoni M; Battaglia P; Castelnuovo P; Antognoni P; Canevari S; Bossi P
    Oral Oncol; 2019 Mar; 90():94-101. PubMed ID: 30846184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal metastasis and elective nodal level treatment in sinonasal small-cell and sinonasal undifferentiated carcinoma: a surveillance, epidemiology and end results analysis.
    Ahn PH; Mitra N; Alonso-Basanta M; Adappa ND; Palmer JN; O'Malley BW; Rassekh CH; Chalian A; Cohen RB; Lin A
    Br J Radiol; 2016; 89(1058):20150488. PubMed ID: 26559439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
    Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F
    Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphoproteomics and Biomedical Analytics Identify the c-Myc, EZH2, Sirt1 and CXCR4 Pathways as Potential Blocks to Differentiation Leading to Proliferation and Metastatic Potential in Sinonasal Undifferentiated Carcinoma (SNUC) and Provide Therapeutic Options: A Case Study.
    Brown RE; Roy S; McGuire MF
    Ann Clin Lab Sci; 2018 Sep; 48(5):659-664. PubMed ID: 30373873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
    Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
    J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal.
    Vaziri Fard E; Zhang S; Cai Z; Ding J; Sun Q; Saluja K; Zhu H
    Hum Pathol; 2019 Jul; 89():62-70. PubMed ID: 31054892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
    Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
    Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
    Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
    Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.